he Institute of Vaccines and Medical Biologicals (IVAC) of Vietnam has announced the successful production of inactivated seasonal influenza vaccine (IVACFLU-S) for commercial use.
Vietnam has successfully produced an inactivated seasonal influenza vaccine. (Source: nld.com.vn)
Hanoi (VNA) - TheInstitute of Vaccines and Medical Biologicals (IVAC) of Vietnam has announcedthe successful production of inactivated seasonal influenzavaccine (IVACFLU-S) for commercial use.
The results were recorded after a period of study, trial and production fromJanuary 2015 to January 2018, according to IVAC.
The vaccine targets three strains of influenza: A/H1N1, A/H3N2 and B.
The production process was in line with instructions of the World HealthOrganisation (WHO) and was assessed to meet quality standards, IVAC said.
Quality assessment and clinical trial results showed that the vaccine metquality and safety standards and was in line with WHO’s warnings and Vietnam’s regulations.
If IVAC is licensed to produce the vaccine it will be sold between 80,000-120,000VND (3.5-5.3 USD) per dose.
At present, Vietnam imports influenza vaccine at a price of 240,000-300,000VND (10.6-13.3 USD) per dose.
IVAC proposed State management agencies to recognise its production line with acapacity of 1.5 million doses per year.
Influenza is a leading cause of morbidity and mortality worldwide. Seasonalinfluenza causes 250,000-500,000 fatalities and up to five million cases ofsevere illness across the globe every year.
If a highly virulent pandemic strain were to emerge, influenza could causemillions of fatalities around the world.
Vietnam reports more than a million cases of influenza-like illnesses everyyear and has reported isolated cases of avian influenza A/H5N1 in humans, astrain with a particularly high fatality rate.
The strain is being monitored for any evolution or adaptations that could turnit into a form that can spread efficiently among people, which will increasethe likelihood of a pandemic.
IVAC, established in 1978 by the Ministry of Health, plans and carries out theproduction of vaccines and serum for the Expanded Programme on Immunisation in Vietnamand the overall prevention and treatment of diseases. It also conducts researchand applies technological advances in vaccine development and production incooperation with organisations both within and outside the country.-VNA
A vaccine factory capable of producing about 1.5 million doses of A/H5N1 influenza vaccine for human use a year became operational on December 12 in the central coastal province of Khanh Hoa.
A phase 1 clinical trial of an inactivated influenza A/H5N1 pandemic vaccine candidate (IVACFLU-H5N1), involving 75 participants in southern Long An province's Ben Luc district, has so far proven to safely induce immune responses at various dosage levels in healthy adults.
Vietnam will produce its own vaccine against avian influenza A/H5N1 from 2018 to replace imported vaccines, according to the National Veterinary JSC, Navetco.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Vietnam has successfully produced an inactivated seasonal influenza vaccine. (Source: nld.com.vn) 
